2022
DOI: 10.31083/j.fbl2705142
|View full text |Cite
|
Sign up to set email alerts
|

Reflections on the Ocular Surface: Summary of the Presentations at the 4th Coronis Foundation Ophthalmic Symposium Debate: “A Multifactorial Approach to Ocular Surface Disorders” (August 31 2021)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 115 publications
0
8
0
Order By: Relevance
“…Hyaluronic acid (HA) eye drops have been reported to have muco-protective and anti-inflammatory effects in in vivo animal and human studies [ 31 ]. HA reduces the OS friction from the blinks and influence aqueous retention.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Hyaluronic acid (HA) eye drops have been reported to have muco-protective and anti-inflammatory effects in in vivo animal and human studies [ 31 ]. HA reduces the OS friction from the blinks and influence aqueous retention.…”
Section: Discussionmentioning
confidence: 99%
“…HA reduces the OS friction from the blinks and influence aqueous retention. The higher the molecular weight of HA, the higher the viscosity attained at the ocular surface when the shear rate becomes small, i.e., vHMWHA eye drops should have a greater stabilizing effect on the tear film during eye opening [ 31 ]. The effect of HA on the immune response also depends on its MW, and vHMWHA is known for its remarkable anti-inflammatory effects.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Hyaluronic acid (HA) is a major carbohydrate component of the extracellular matrix (ECM) and a high-molecular-weight glycosaminoglycan that is widely distributed throughout the body. High-molecular-weight HA (HiHA: 1.5-1.7 MDa, intrinsic viscosity 2.5-<2.9 m 3 /kg) and very HiHA (vHiHA: ≥1.8 MDa, intrinsic viscosity ≥ 2.9 m 3 /kg) [10,11] Pharmaceutics 2024, 16, 523 2 of 10 have anti-inflammatory and wound-healing effects that are associated with their antiangiogenic and immunosuppressive properties, and they are widely used in the treatment of dry eye [12][13][14][15][16][17][18][19]. These studies suggest that when an anti-glaucoma medication like LP is combined with a vHiHA-containing vehicle, IOP may be decreased with only minor effects on the ocular surface.…”
Section: Introductionmentioning
confidence: 99%
“…Dry eye disease (DED) is a prevalent multifactorial eye condition caused by insufficient tear production or excessive tear evaporation [ 1 , 2 , 3 ]. It can lead to damage of the eye surface with symptoms such as irritation, redness, itchiness, dryness, fatigue, and foreign body sensation [ 3 , 4 , 5 , 6 , 7 ]. DED is a significant public health concern and one of the leading causes of seeking ophthalmological care [ 5 , 7 ].…”
Section: Introductionmentioning
confidence: 99%